For PE Firms
Most lower middle market manufacturing companies in a PE portfolio share a version of the same problem.
Commercial commitments and operational delivery are not in sync. Salespeople have learned not to trust what the floor tells them, so they build margin into their timelines. Operations plans for one set of inputs and receives another. The result is cost, strain, and missed targets that feel like execution failures but trace back to a structural misalignment.
The fix is usually closer than it looks. But finding it requires seeing both sides of the system at the same time.
How M5 Deploys in a Portfolio
M5 enters through a structured diagnostic, 30 to 45 days at a fixed fee of $25K to $40K. This is a low-risk entry point for a portfolio company. The diagnostic surfaces what is actually driving the gap between commercial performance and operational output.
If the diagnostic confirms fit, M5 moves into a full engagement at $15K to $20K per month. The typical arc is 24 to 36 months, structured to build internal capability rather than dependency.
For PE firms with multiple portfolio companies, M5 provides consistent reporting architecture and board-level visibility across assets. The principal network model means M5 can deploy the right expertise across different portfolio situations without compromising depth.